Neuroendocrine Tumors,Gastroenteropancreatic
1 clinical trials · Condition
◉ Watch Neuroendocrine Tumors,Gastroenteropancreatic
| Record | Firm | Date |
|---|---|---|
| Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors (NCT05048901) | National Health Research Institutes, Taiwan | 2021-09-17 |
Track Neuroendocrine Tumors,Gastroenteropancreatic automatically
Every clearance here is in the API, with alerts when new ones post.